At what point does Advisory Committee on Medicines or Advisory Committee on Vaccines (ACM/ACV) input MOST directly influence the regulatory outcome?

Question

BlackTom AI · Accepted Answer

Advisory Committees are called when clinical, safety or benefit–risk uncertainties remain after the technical assessment and just before the regulator finalises a recommendation, so their input is timed to influence the delegate’s decision.

1) Relevant knowledge points and concepts
- Regulatory review proceeds in phases: pre-submission advice (Phase 1), first-round assessment (Phase 3), possible second-round assessment (Phase 5), then a delegate decision and final decision.  
- Advisory Committees on Medicines/Vaccines (ACM/ACV) provide expert scientific and clinical advice to resolve outstanding issues that affect benefit–risk and conditions of approval.  
- Their role is advisory to the delegate; they advise before the decision is made rather than after.

2) Step-by-step reasoning process
Step 1: Early phases (Phase 1) are for sponsor preparation and do not rely on committee input to determine regulatory outcome; committee advice here is formative, not decisive.  
Step 2: After Phase 3 (first-round assessment) sponsors typically respond to deficiencies; the assessment is not yet complete and many issues remain open, so committee input at that time would be premature.  
Step 3: After Phase 5 (second-round assessment) the assessor has integrated sponsor responses and narrowed the issues to remaining key questions. This is when unresolved scientific or clinical uncertainties are clear and when expert committee opinion can directly change the recommendation the delegate will make.  
Step 4: After the final decision is too late — committee input cannot influence an already-made regulatory outcome.

3) Intermediate steps shown
- Phase 1 → preparatory (limited direct influence)  
- Phase 3 → initial assessment (issues identified, sponsor response pending)  
- Phase 5 → second-round assessment (issues narrowed, ready for advisory input)  
- Delegate decision → final regulatory action (advisory input must arrive before this)

4) Why the correct answer is correct
Because the committee’s role is to resolve remaining scientific/clinical uncertainties just before the regulator’s decision, the timing when it most directly influences outcome is after the second-round assessment and before the delegate decides.

5) Why other options are incorrect
a) After Phase 3: still too early; sponsor can still respond and issues are not final.  
b) After the final decision: too late to influence the outcome.  
c) After Phase 1: too preliminary; committee advice here is not the decisive input.

Conclusion: The best choice is d. After Phase 5 (second round assessment), before the delegate decision — this matches the provided correct answer.

At what point does Advisory Committee on Medicines or Advisory Committee on Vaccines (ACM/ACV) input MOST directly influence the regulatory outcome?单项选择题

类似问题

What was the world's first widely adopted biodiversity policy?

The aim of the Paris Agreement is to ensure that the earth’s preindustrial temperature is not exceeded by more than º Celsius.

The IPCC's mission is to Blank ______.

Why have most international agreements for environmental protection been based on the honor system?

As was exhibited with the Montreal Protocol and the encouragement of reduced CFC production, trade can be an effective tool to compel compliance with international treaties.

The Stockholm Declaration and UNEP were the result of the Blank ______ first conference on the Human Environment in 1972.

In addition to the direct mission of the Convention on International Trade in Endangered Species (CITES), why was CITES so important?

President Trump hiring a corporate leader from the oil and gas industry to head the Department of Energy is an example of regulatory ; one intention behind this was to change environmental policy.

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单